Evidence map›Paper›PMID 35708778›Full record

ReviewClinical and experimental medicine2023

New concepts in regulation and function of the FGF23.

Sanaz Dastghaib, Farhad Koohpeyma, Mesbah Shams, Forough Saki, Aliakbar Alizadeh

Abstract readReview
PubMed Publisher
In one paragraph

Review in Clinical and experimental medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Bone: A Neglected Endocrine Organ?Journal of clinical medicine · 2024
    Review
  6. The basics of phosphate metabolism.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2024
    Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sanaz DastghaibEndocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, P.O. Box 71345-1744, Iran.ORCID http://orcid.org/0000-0001-8553-9221
Farhad KoohpeymaEndocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, P.O. Box 71345-1744, Iran.ORCID http://orcid.org/0000-0001-6729-7732
Mesbah ShamsEndocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, P.O. Box 71345-1744, Iran.ORCID http://orcid.org/0000-0002-3210-0159
Forough SakiEndocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, P.O. Box 71345-1744, Iran. Sakeif@sums.ac.ir.ORCID http://orcid.org/0000-0003-1900-5242
Aliakbar AlizadehEndocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, P.O. Box 71345-1744, Iran. alializadeha@gmail.com.ORCID http://orcid.org/0000-0002-8766-8163
Shiraz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In comparison to the regulation of calcium homeostasis, which has been widely studied over the last several decades, phosphate homeostasis is little understood. The parathyroid hormone (PTH)/vitamin D axis has traditionally been used as a conceptual framework for understanding mineral metabolism. Recently, the fundamental regulator of phosphate homeostasis, fibroblast growth factor 23 (FGF23), which is produced by osteocytes and is involved in the hormonal bone-parathyroid-kidney axis, has attracted more attention. The secretion of FGF23 is controlled by diet, serum phosphate levels, PTH, and 1,25(OH)2 vitamin D. FGF-23, the FGF receptors and the obligate co-receptor α-Klotho work in concert to affect FGF-23 actions on targeted organs. Despite all efforts to investigate pleotropic effects of FGF23 in various endocrine organs, many aspects of the regulation and functions of FGF23 and the exact crosstalk among FGF23, serum phosphate, calcium, PTH, and vitamin D in the regulation of mineral homeostasis remain unclear; much efforts need to be established before it can be moved toward therapeutic applications. In this regard, we provide a brief overview of the novel findings in the regulation and function of FGF23 and refer to related questions and hypotheses not answered yet, which can be a window for future projects. We also focus on the current knowledge about the role of FGF23 obtained from our researches in recent years.

Indexed as

CalciumKlotho ProteinsFibroblast Growth FactorsGlucuronidaseHumansMineralsParathyroid HormonePhosphatesVitamin DCalciumFibroblast Growth FactorsGlucuronidaseKlotho ProteinsMineralsParathyroid HormonePhosphatesVitamin D1,25(OH)2DFGF23PO4PTH

Identifiers

PMID35708778
OpenAlexW4283025022

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.